Now Hiring: Are you a driven and motivated 1st Line IT Support Engineer?


Halley Losekamp Joins BEKHealth as Vice President of Corporate Strategy

Press Release

Halley Losekamp Joins BEKHealth as Vice President of Corporate Strategy

Clinical research veteran to support growth strategy, expand partnerships and increase visibility with pharmaceutical sponsors.

Stamford, CT – February 28, 2022 – BEKHealth, a Clinical Research Platform
company, today announced the appointment of Halley Losekamp as Vice President of
Corporate Strategy. Halley will assume responsibility for developing and executing
BEKHealth’s corporate strategy, operations planning, partner engagement, and
business model design. She brings to BEKHealth more than 12 years of clinical
research experience across multiple domains, with a focus on driving patient
recruitment, enrollment, and retention strategies for clinical trials at all stages.

“As a champion of Clinical Research as a Care Option concept, I believe BEKHealth is
uniquely positioned to elevate the movement and provide opportunities for more people
to participate in potentially life-altering and lifesaving clinical trials,” said Losekamp. “I
am excited for the opportunity to help the company expand partnerships and client
engagements and contribute to BEKHealth’s overall growth and success.”

Throughout her career, Halley held a wide range of positions within the clinical research
and pharmaceutical arenas. Immediately before joining BEKHealth, she was Director of
Patient Enrollment at Applied Genetic Technologies Corporation where, as part of the
clinical operations leadership team, she led strategic planning around clinical operations
and developed implementations studies and site-specific patient recruitment and
retention plans. Halley has held a variety of patient recruitment-related positions
throughout her career, including at Covance Clinical Development Services, PRA
Health Sciences, Continuum Clinical Patient Recruitment, and Cincinnati Children’s
Hospital. She is a graduate of the University of Cincinnati.

“With her extensive experience in both real-world clinical research settings and
pharmaceuticals, Halley is uniquely qualified to advance our mission of servicing these
two interconnected markets while minimizing the operational barriers between them,”
said Jason Baumgartner, BEKHealth CEO. “We are excited to welcome Halley to
BEKHealth during this time of exponential growth for the company.”